Azacytidine Treatment for VEXAS Syndrome

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

48 Citations (Scopus)

148 Downloads (Pure)

Access to Document

@article{717946d5a9cf4467bdb479a1ae0021f9,

title = "Azacytidine Treatment for VEXAS Syndrome",

author = "Marc Raaijmakers and Maud Hermans and Anna Aalbers and Melissa Rijken and Dalm, {Virgil A.S.H.} and {van Daele}, Paul and Peter Valk",

note = "Copyright {\textcopyright} 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.",

year = "2021",

month = dec,

doi = "10.1097/HS9.0000000000000661",

language = "English",

volume = "5",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley & Sons Inc.",

number = "12",

}

TY - JOUR

T1 - Azacytidine Treatment for VEXAS Syndrome

AU - Raaijmakers, Marc

AU - Hermans, Maud

AU - Aalbers, Anna

AU - Rijken, Melissa

AU - Dalm, Virgil A.S.H.

AU - van Daele, Paul

AU - Valk, Peter

PY - 2021/12

Y1 - 2021/12

U2 - 10.1097/HS9.0000000000000661

DO - 10.1097/HS9.0000000000000661

M3 - Article

SN - 2572-9241

VL - 5

JO - HemaSphere

JF - HemaSphere

IS - 12

ER -